Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Anti-calponin-3 autoantibodies: a new specificity in patients with Sjögren's syndrome.

Birnbaum J, Hoke A, Lalji A, Calabresi P, Bhargava P, Casciola-Rosen L.

Arthritis Rheumatol. 2018 May 11. doi: 10.1002/art.40550. [Epub ahead of print]

PMID:
29749720
2.

Different ketogenesis strategies lead to disparate seizure outcomes.

Dolce A, Santos P, Chen W, Hoke A, Hartman AL.

Epilepsy Res. 2018 Jul;143:90-97. doi: 10.1016/j.eplepsyres.2018.04.011. Epub 2018 Apr 27.

PMID:
29723773
3.

Altered fecal microbiota composition in all male aggressor-exposed rodent model simulating features of post-traumatic stress disorder.

Gautam A, Kumar R, Chakraborty N, Muhie S, Hoke A, Hammamieh R, Jett M.

J Neurosci Res. 2018 Jul;96(7):1311-1323. doi: 10.1002/jnr.24229. Epub 2018 Apr 6.

PMID:
29633335
4.

Increased Single-Fiber Jitter Level Is Associated With Reduction in Motor Function With Aging.

Chung T, Tian Y, Walston J, Hoke A.

Am J Phys Med Rehabil. 2018 Aug;97(8):551-556. doi: 10.1097/PHM.0000000000000915.

PMID:
29498943
5.

Novel hemizygous nonsense mutation in DRP2 is associated with inherited neuropathy.

Roda RH, McCray BA, Klein CJ, Hoke A.

Neurol Genet. 2018 Jan 24;4(1):e220. doi: 10.1212/NXG.0000000000000220. eCollection 2018 Feb. No abstract available.

6.

Gene-metabolite profile integration to understand the cause of spaceflight induced immunodeficiency.

Chakraborty N, Cheema A, Gautam A, Donohue D, Hoke A, Conley C, Jett M, Hammamieh R.

NPJ Microgravity. 2018 Jan 29;4:4. doi: 10.1038/s41526-017-0038-4. eCollection 2018.

7.

NaV channel variants in patients with painful and nonpainful peripheral neuropathy.

Wadhawan S, Pant S, Golhar R, Kirov S, Thompson J, Jacobsen L, Qureshi I, Ajroud-Driss S, Freeman R, Simpson DM, Smith AG, Hoke A, Bristow LJ.

Neurol Genet. 2017 Dec 15;3(6):e207. doi: 10.1212/NXG.0000000000000207. eCollection 2017 Dec.

8.

Quality of local school wellness policies for physical activity and resultant implementation in Pennsylvania schools.

Francis E, Hivner E, Hoke A, Ricci T, Watach A, Kraschnewski J.

J Public Health (Oxf). 2017 Sep 28:1-7. doi: 10.1093/pubmed/fdx130. [Epub ahead of print]

PMID:
29036317
9.

Photoacoustic imaging for in vivo quantification of placental oxygenation in mice.

Yamaleyeva LM, Sun Y, Bledsoe T, Hoke A, Gurley SB, Brosnihan KB.

FASEB J. 2017 Dec;31(12):5520-5529. doi: 10.1096/fj.201700047RR. Epub 2017 Aug 21.

PMID:
28842425
10.

Molecular indicators of stress-induced neuroinflammation in a mouse model simulating features of post-traumatic stress disorder.

Muhie S, Gautam A, Chakraborty N, Hoke A, Meyerhoff J, Hammamieh R, Jett M.

Transl Psychiatry. 2017 May 23;7(5):e1135. doi: 10.1038/tp.2017.91.

11.

HSP and deafness: Neurocristopathy caused by a novel mosaic SOX10 mutation.

Donkervoort S, Bharucha-Goebel D, Yun P, Hu Y, Mohassel P, Hoke A, Zein WM, Ezzo D, Atherton AM, Modrcin AC, Dasouki M, Foley AR, Bönnemann CG.

Neurol Genet. 2017 May 15;3(3):e151. doi: 10.1212/NXG.0000000000000151. eCollection 2017 Jun.

12.

Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy.

Turkiew E, Falconer D, Reed N, Höke A.

J Peripher Nerv Syst. 2017 Sep;22(3):162-171. doi: 10.1111/jns.12219.

13.

Deficiency of adaptive immunity does not interfere with Wallerian degeneration.

Cashman CR, Hoke A.

PLoS One. 2017 May 5;12(5):e0177070. doi: 10.1371/journal.pone.0177070. eCollection 2017.

14.

An Intrinsic Epigenetic Barrier for Functional Axon Regeneration.

Weng YL, An R, Cassin J, Joseph J, Mi R, Wang C, Zhong C, Jin SG, Pfeifer GP, Bellacosa A, Dong X, Hoke A, He Z, Song H, Ming GL.

Neuron. 2017 Apr 19;94(2):337-346.e6. doi: 10.1016/j.neuron.2017.03.034.

15.

Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress.

Karl JP, Margolis LM, Madslien EH, Murphy NE, Castellani JW, Gundersen Y, Hoke AV, Levangie MW, Kumar R, Chakraborty N, Gautam A, Hammamieh R, Martini S, Montain SJ, Pasiakos SM.

Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G559-G571. doi: 10.1152/ajpgi.00066.2017. Epub 2017 Mar 23.

16.

GDE2 is essential for neuronal survival in the postnatal mammalian spinal cord.

Cave C, Park S, Rodriguez M, Nakamura M, Hoke A, Pletnikov M, Sockanathan S.

Mol Neurodegener. 2017 Jan 19;12(1):8. doi: 10.1186/s13024-017-0148-1.

17.

Evolutionary perspectives: Introduction to the special issue on Axon Regeneration Across Species.

He Z, Höke A.

Exp Neurol. 2017 Jan;287(Pt 3):299. doi: 10.1016/j.expneurol.2016.11.011. No abstract available.

PMID:
27912838
18.

The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons.

Ehmsen JT, Liu Y, Wang Y, Paladugu N, Johnson AE, Rothstein JD, du Lac S, Mattson MP, Höke A.

Sci Rep. 2016 Oct 19;6:35592. doi: 10.1038/srep35592.

19.

Identification of extracellular miRNA in archived serum samples by next-generation sequencing from RNA extracted using multiple methods.

Gautam A, Kumar R, Dimitrov G, Hoke A, Hammamieh R, Jett M.

Mol Biol Rep. 2016 Oct;43(10):1165-78. doi: 10.1007/s11033-016-4043-6. Epub 2016 Aug 10.

20.

A Novel Rodent Orthotopic Forelimb Transplantation Model That Allows for Reliable Assessment of Functional Recovery Resulting From Nerve Regeneration.

Kern B, Budihardjo JD, Mermulla S, Quan A, Cadmi C, Lopez J, Khusheim M, Xiang S, Park J, Furtmüller GJ, Sarhane KA, Schneeberger S, Lee WP, Hoke A, Tuffaha SH, Brandacher G.

Am J Transplant. 2017 Mar;17(3):622-634. doi: 10.1111/ajt.14007. Epub 2016 Sep 12.

21.

A Spontaneous Missense Mutation in Branched Chain Keto Acid Dehydrogenase Kinase in the Rat Affects Both the Central and Peripheral Nervous Systems.

Zigler JS Jr, Hodgkinson CA, Wright M, Klise A, Sundin O, Broman KW, Hejtmancik F, Huang H, Patek B, Sergeev Y, Hose S, Brayton C, Xaiodong J, Vasquez D, Maragakis N, Mori S, Goldman D, Hoke A, Sinha D.

PLoS One. 2016 Jul 29;11(7):e0160447. doi: 10.1371/journal.pone.0160447. eCollection 2016.

22.

Evidence for dying-back axonal degeneration in age-associated skeletal muscle decline.

Chung T, Park JS, Kim S, Montes N, Walston J, Höke A.

Muscle Nerve. 2017 Jun;55(6):894-901. doi: 10.1002/mus.25267. Epub 2017 Apr 1.

23.

An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats.

Scheib JL, Höke A.

Neurobiol Aging. 2016 Sep;45:1-9. doi: 10.1016/j.neurobiolaging.2016.05.004. Epub 2016 May 11.

PMID:
27459920
24.

Impaired regeneration in aged nerves: Clearing out the old to make way for the new.

Scheib J, Höke A.

Exp Neurol. 2016 Oct;284(Pt A):79-83. doi: 10.1016/j.expneurol.2016.07.010. Epub 2016 Jul 21. Review.

PMID:
27451012
25.

Caspase-3 dependent nitrergic neuronal apoptosis following cavernous nerve injury is mediated via RhoA and ROCK activation in major pelvic ganglion.

Hannan JL, Matsui H, Sopko NA, Liu X, Weyne E, Albersen M, Watson JW, Hoke A, Burnett AL, Bivalacqua TJ.

Sci Rep. 2016 Jul 8;6:29416. doi: 10.1038/srep29416.

26.

Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity.

Zhu J, Carozzi VA, Reed N, Mi R, Marmiroli P, Cavaletti G, Hoke A.

Sci Rep. 2016 Jun 28;6:28861. doi: 10.1038/srep28861.

27.

Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand bias.

Keller RR, Gestl SA, Lu AQ, Hoke A, Feith DJ, Gunther EJ.

Carcinogenesis. 2016 Aug;37(8):810-816. doi: 10.1093/carcin/bgw061. Epub 2016 May 17.

28.

Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury.

Tuffaha SH, Singh P, Budihardjo JD, Means KR, Higgins JP, Shores JT, Salvatori R, Höke A, Lee WP, Brandacher G.

Expert Opin Ther Targets. 2016 Oct;20(10):1259-65. doi: 10.1080/14728222.2016.1188079. Epub 2016 May 24. Review.

PMID:
27192539
29.

Identification of fluocinolone acetonide to prevent paclitaxel-induced peripheral neuropathy.

Cetinkaya-Fisgin A, Joo MG, Ping X, Thakor NV, Ozturk C, Hoke A, Yang IH.

J Peripher Nerv Syst. 2016 Sep;21(3):128-33. doi: 10.1111/jns.12172.

PMID:
27117347
30.

Longitudinal Assessment of Small Fiber Neuropathy: Evidence of a Non-Length-Dependent Distal Axonopathy.

Khoshnoodi MA, Truelove S, Burakgazi A, Hoke A, Mammen AL, Polydefkis M.

JAMA Neurol. 2016 Jun 1;73(6):684-90. doi: 10.1001/jamaneurol.2016.0057.

PMID:
27065313
31.

Growth Hormone Therapy Accelerates Axonal Regeneration, Promotes Motor Reinnervation, and Reduces Muscle Atrophy following Peripheral Nerve Injury.

Tuffaha SH, Budihardjo JD, Sarhane KA, Khusheim M, Song D, Broyles JM, Salvatori R, Means KR Jr, Higgins JP, Shores JT, Cooney DS, Hoke A, Lee WP, Brandacher G.

Plast Reconstr Surg. 2016 Jun;137(6):1771-80. doi: 10.1097/PRS.0000000000002188.

PMID:
26890510
32.

Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.

Ostrow KL, Donaldson K, Blakeley J, Belzberg A, Hoke A.

PLoS One. 2015 Dec 14;10(12):e0144620. doi: 10.1371/journal.pone.0144620. eCollection 2015.

33.

Use of engineered Schwann cells in peripheral neuropathy: Hopes and hazards.

Lehmann HC, Höke A.

Brain Res. 2016 May 1;1638(Pt A):97-104. doi: 10.1016/j.brainres.2015.10.040. Epub 2015 Oct 31. Review.

PMID:
26529642
34.

Improving Community Health While Satisfying a Critical Community Need: A Case Study for Nonprofit Hospitals.

Hoke AM, Kephart DK, Dillon JF, McCullough JR, Blatt BJ, Kraschnewski JL.

Prev Chronic Dis. 2015 Oct 29;12:E185. doi: 10.5888/pcd12.150230.

35.

Paclitaxel inhibits mRNA transport in axons.

Bobylev I, Joshi AR, Barham M, Ritter C, Neiss WF, Höke A, Lehmann HC.

Neurobiol Dis. 2015 Oct;82:321-331. doi: 10.1016/j.nbd.2015.07.006. Epub 2015 Jul 15.

PMID:
26188177
36.

An exercise regimen prevents development paclitaxel induced peripheral neuropathy in a mouse model.

Park JS, Kim S, Hoke A.

J Peripher Nerv Syst. 2015 Mar;20(1):7-14. doi: 10.1111/jns.12109.

PMID:
25858462
37.

Temporal changes in neurotrophic factors and neurite outgrowth in the major pelvic ganglion following cavernous nerve injury.

Hannan JL, Albersen M, Stopak BL, Liu X, Burnett AL, Hoke A, Bivalacqua TJ.

J Neurosci Res. 2015 Jun;93(6):954-63. doi: 10.1002/jnr.23553. Epub 2015 Jan 19.

38.

GGF2 is neuroprotective in a rat model of cavernous nerve injury-induced erectile dysfunction.

Burnett AL, Sezen SF, Hoke A, Caggiano AO, Iaci J, Lagoda G, Musicki B, Bella AJ.

J Sex Med. 2015 Apr;12(4):897-905. doi: 10.1111/jsm.12834. Epub 2015 Jan 30.

39.

Mechanisms of distal axonal degeneration in peripheral neuropathies.

Cashman CR, Höke A.

Neurosci Lett. 2015 Jun 2;596:33-50. doi: 10.1016/j.neulet.2015.01.048. Epub 2015 Jan 21. Review.

40.

Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain.

Kageyama Y, Hoshijima M, Seo K, Bedja D, Sysa-Shah P, Andrabi SA, Chen W, Höke A, Dawson VL, Dawson TM, Gabrielson K, Kass DA, Iijima M, Sesaki H.

EMBO J. 2014 Dec 1;33(23):2798-813. doi: 10.15252/embj.201488658. Epub 2014 Oct 27.

41.

Designing innovative therapies for neuropathic pain: preclinical and early clinical development challenges.

Höke A, Simpson DM, Freeman R.

J Peripher Nerv Syst. 2014 Oct;19 Suppl 2:S28-9. doi: 10.1111/jns.12082. No abstract available.

PMID:
25269739
42.

Journal of the Peripheral Nervous System. Supplement: Designing innovative therapies for neuropathic pain: 2014 FPN International Research Symposium. Introduction.

Höke A, Simpson DM, Freeman R.

J Peripher Nerv Syst. 2014 Oct;19 Suppl 2:S1. doi: 10.1111/jns.12078. No abstract available.

PMID:
25269726
43.

Treadmill exercise induced functional recovery after peripheral nerve repair is associated with increased levels of neurotrophic factors.

Park JS, Höke A.

PLoS One. 2014 Mar 11;9(3):e90245. doi: 10.1371/journal.pone.0090245. eCollection 2014.

44.

Rodent models of chemotherapy-induced peripheral neuropathy.

Höke A, Ray M.

ILAR J. 2014;54(3):273-81. doi: 10.1093/ilar/ilt053. Review.

PMID:
24615440
45.

Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition.

MacDonald EM, Andres-Mateos E, Mejias R, Simmers JL, Mi R, Park JS, Ying S, Hoke A, Lee SJ, Cohn RD.

Dis Model Mech. 2014 Apr;7(4):471-81. doi: 10.1242/dmm.014126. Epub 2014 Feb 6.

46.

Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration.

Wright MC, Mi R, Connor E, Reed N, Vyas A, Alspalter M, Coppola G, Geschwind DH, Brushart TM, Höke A.

J Neurosci. 2014 Jan 29;34(5):1689-700. doi: 10.1523/JNEUROSCI.3822-13.2014.

47.

Augmenting glial cell-line derived neurotrophic factor signaling to treat painful neuropathies.

Höke A.

Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2060-1. doi: 10.1073/pnas.1324047111. Epub 2014 Jan 28. No abstract available.

48.

Advances in peripheral nerve regeneration.

Scheib J, Höke A.

Nat Rev Neurol. 2013 Dec;9(12):668-76. doi: 10.1038/nrneurol.2013.227. Epub 2013 Nov 12. Review.

PMID:
24217518
49.

Ethoxyquin prevents chemotherapy-induced neurotoxicity via Hsp90 modulation.

Zhu J, Chen W, Mi R, Zhou C, Reed N, Höke A.

Ann Neurol. 2013 Dec;74(6):893-904. doi: 10.1002/ana.24004.

PMID:
23955554
50.

High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.

Lewis RA, McDermott MP, Herrmann DN, Hoke A, Clawson LL, Siskind C, Feely SM, Miller LJ, Barohn RJ, Smith P, Luebbe E, Wu X, Shy ME; Muscle Study Group.

JAMA Neurol. 2013 Aug;70(8):981-7. doi: 10.1001/jamaneurol.2013.3178.

Supplemental Content

Support Center